ANDA 74114, held by Watson Labs. Dobutamine Hydrochloride.
As of Nov 16, 2026, ANDA 74114 (Dobutamine Hydrochloride), held by Watson Labs, was first approved by FDA on Nov 30, 1993, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 30, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dobutamine HydrochlorideEQ 12.5MG BASE/ML ยท injectable;injection | Dobutamine Hydrochloride | Discontinued |
| Feb 19, 1999 | Supplement 5Manufacturing | Approved | None posted |
| Feb 2, 1999 | Supplement 4Manufacturing | Approved | None posted |
| Aug 28, 1998 | Supplement 3Manufacturing | Approved | None posted |
| Dec 4, 1996 | Supplement 2Manufacturing | Approved | None posted |
| Jul 31, 1996 | Supplement 1Labeling | Approved | None posted |
| Nov 30, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters